1. Home
  2. BIO vs AU Comparison

BIO vs AU Comparison

Compare BIO & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • AU
  • Stock Information
  • Founded
  • BIO 1952
  • AU 1944
  • Country
  • BIO United States
  • AU United States
  • Employees
  • BIO N/A
  • AU 33658
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • AU Precious Metals
  • Sector
  • BIO Industrials
  • AU Basic Materials
  • Exchange
  • BIO Nasdaq
  • AU Nasdaq
  • Market Cap
  • BIO 9.1B
  • AU 10.3B
  • IPO Year
  • BIO N/A
  • AU 1972
  • Fundamental
  • Price
  • BIO $322.15
  • AU $24.53
  • Analyst Decision
  • BIO Strong Buy
  • AU Hold
  • Analyst Count
  • BIO 4
  • AU 4
  • Target Price
  • BIO $411.00
  • AU $33.67
  • AVG Volume (30 Days)
  • BIO 211.4K
  • AU 2.4M
  • Earning Date
  • BIO 10-30-2024
  • AU 11-07-2024
  • Dividend Yield
  • BIO N/A
  • AU 0.91%
  • EPS Growth
  • BIO N/A
  • AU N/A
  • EPS
  • BIO N/A
  • AU 1.34
  • Revenue
  • BIO $2,580,209,000.00
  • AU $5,299,000,000.00
  • Revenue This Year
  • BIO N/A
  • AU $27.72
  • Revenue Next Year
  • BIO $3.61
  • AU $8.05
  • P/E Ratio
  • BIO N/A
  • AU $18.75
  • Revenue Growth
  • BIO N/A
  • AU 17.78
  • 52 Week Low
  • BIO $262.12
  • AU $15.80
  • 52 Week High
  • BIO $387.99
  • AU $32.57
  • Technical
  • Relative Strength Index (RSI)
  • BIO 39.02
  • AU 40.57
  • Support Level
  • BIO $306.42
  • AU $24.02
  • Resistance Level
  • BIO $387.99
  • AU $25.36
  • Average True Range (ATR)
  • BIO 12.82
  • AU 0.77
  • MACD
  • BIO -5.89
  • AU -0.15
  • Stochastic Oscillator
  • BIO 21.17
  • AU 36.37

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

Share on Social Networks: